Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
NCT04305834
This study is recruiting at 6 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
This phase IIa trial studies the side effects of abemaciclib monotherapy in treating patients age 70 years and older with hormone receptor positive, HER2 negative breast cancer that has spread to other places in the body.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anatomic Stage IV Breast Cancer AJCC v8
- Hormone Receptor Positive Breast Carcinoma
- Metastatic Breast Carcinoma
- Prognostic Stage IV Breast Cancer AJCC v8
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 70 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- City of Hope Medical Center
- Last updated on ClinicalTrials.gov
- October 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 4
- City of Hope Medical Center · Duarte, CA
- City of Hope at Irvine Lennar · Irvine, CA
- City of Hope at Long Beach Elm · Long Beach, CA
- City of Hope South Pasadena · South Pasadena, CA
Massachusetts · 1
- Dana Farber Cancer Institute · Boston, MA
New York · 1
- Roswell Park Comprehensive Cancer Center · Buffalo, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.